Association between aflatoxin exposure and health characteristics, liver function, hepatitis and malaria infections in Ghanaians

References

• Gourama H., Bullerman L. B. Aspergillus flavus and Aspergillus parasiticus, aflatoxigenic fungi of concern in foods and feed – a review. J Food Protect 1995; 58: 1395–404
   PubMed Web of Science ®Google Scholar
• Fung F., Clark R. F. Health effects of mycotoxins: a toxicological overview. J Toxicol 2004; 42: 217–34
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention (CDC). Outbreak of aflatoxin poisoning – Easter and Central Provinces, Kenya. January–June 2004. Morbid Mortal Weekly Rep 2004; 53: 790–3
   PubMedGoogle Scholar
• Ngindu A., Johnson B. K., Kenya P. R., Ngira J. A., Ocheng D. M., Nandwa H., Omondi T. N., Jansen A. J., Ngare W., Kaviti J. N., Gatei D., Siongok T. A. Outbreak of acute hepatitis by aflatoxin poisoning in Kenya. Lancet 1982; 1: 1346–8
   PubMed Web of Science ®Google Scholar
• Krishnamachari K. A., Nagaarajan V., Bhat R. V., Tilak T. B. Hepatitis due to aflatoxicosis – an outbreak in Western India. Lancet 1975; 305: 1061–3
   Google Scholar
• Chao T. C., Maxwell S. M., Wong S. Y. An outbreak of aflatoxicosis and boric acid poisoning in Malaysia: a clinicopathological study. J Pathol 1991; 164: 225–33
   PubMed Web of Science ®Google Scholar
• Lye M. S., Ghazali A. A., Mohan J., Alwin N., Mair R. C. An outbreak of acute hepatic encephalopathy due to severe aflatoxicosis in Malaysia. Am J Trop Med Hygiene 1995; 53: 68–72
   PubMed Web of Science ®Google Scholar
• Shane S. M. Economic issues associated with aflatoxins. The toxicology of aflatoxins: human health, veterinary, and agricultural significance, D. L Eaton, J. D Groopman. Academic Press, London 1993; 513–27
   Google Scholar
• Gong Y. Y., Cardwell K., Hounsa A., Turner P. C., Hall A. J., Wild C. P. Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study. Br Med J 2002; 325: 20–1
   PubMed Web of Science ®Google Scholar
• Gong Y. Y., Hounsa A., Egal S., Turner P. C., Sutcliffe A. E., Hall A. J., Cardwell K., Wild C. P. Postweaning exposure to aflatoxin results in impaired child growth: a longitudinal study in Benin, West Africa. Environ Health Perspect 2004; 112: 1334–8
   PubMed Web of Science ®Google Scholar
• Pimpukdee K., Kubena L. F., Bailey C. A., Huebner H. J., Afriyie‐Gyawu E., Phillips T. D. Aflatoxin‐induced toxicity and depletion of hepatic vitamin A in young broiler chicks: protection of chicks in the presence of low levels of Novasil Plus(TM) in the diet. Poultry Sci 2004; 83: 737–44
   PubMed Web of Science ®Google Scholar
• Reddy K. V., Rao P. V., Reddy V. R. Effect of aflatoxin on the performance of broiler chicks fed diets supplemented with vitamin A. Indian J Animal Sci 1989; 59: 140–4
   Google Scholar
• Abbas T., Ali B. Retinol values in the plasma of the Arabian camel (Camelus dromedarius) and the influence of aflatoxicosis. Vet Res Commun 2001; 25: 517–22
   PubMedGoogle Scholar
• Glahn R. P., Beers K. W., Bottje W. G., Wideman R. J., Huff W. E., Thomas W. Aflatoxicosis alters avian renal function, calcium, and vitamin D metabolism. J Toxicol Environ Health 1991; 34: 309–21
   PubMed Web of Science ®Google Scholar
• Kalorey D. R., Daginawala H. F., Ganorkar A. G., Mangle N. Serum zinc and iron status in experimental aflatoxicosis in chicks. Indian J Vet Res 1996; 5: 28–32
   Google Scholar
• Mocchegiani E., Corradi A., Santarelli L., Tibaldi A., DeAngelis E., Borghetti P., Bonomi A., Fabris N., Cabassi E. Zinc, thymic endocrine activity and mitogen responsiveness (PHA) in piglets exposed to maternal aflatoxicosis B1 and G1. Vet Immunol Immunopathol 2001; 62: 245–60
   Google Scholar
• Chen S. Y., Chen C. J., Tsai W. Y., Ahsan H., Liu T. Y., Lin J. T., Santella T. M. Associations of plasma aflatoxin B1‐albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S‐transferase M1 and T1. Nutr Cancer 2000; 38: 179–85
   PubMed Web of Science ®Google Scholar
• IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1996; 56: 245–395
   Google Scholar
• Ali M. V., Mohiuddin S. M., Reddy M. V. Effect of dietary aflatoxin on cell mediated immunity and serum proteins in broiler chicken. Indian Vet J 1994; 71: 760–2
   Google Scholar
• Azzam A. H., Gabal M. A. Aflatoxin and immunity in layer hens. Avian Pathol 1998; 27: 570–7
   PubMed Web of Science ®Google Scholar
• Gabal M. A., Azzam A. H. Interaction of aflatoxin in the feed and immunization against selected infectious diseases in poultry. II. Effect on one‐day‐old layer chicks simultaneously vaccinated against Newcastle disease, infectious bronchitis and infectious bursal disease. Avian Pathol 1998; 27: 290–5
   PubMed Web of Science ®Google Scholar
• Neiger R. D., Johnson T. J., Hurley D. J., Higgins K. F., Rottinghaus G. E., Stahr H. The short‐term effect of low concentrations of dietary aflatoxin and R‐2 toxin on mallard ducklings. Avian Dis 1994; 38: 738–43
   PubMedGoogle Scholar
• Pestka J. J., Bondy G. S. Mycotoxin‐induced immunomodulation. Immunotoxicology and immunopharmacology, J. H Dean, M. I Luster, A. E Munson, I Kimber. Raven Press, New York 1994; 163–82
   Google Scholar
• Pier A. C. Immunologic changes associated with mycotoxicoses. 13. Immunomodulation in aflotoxicosis. Diagnosis of mycotoxicosis, J. L Richard, J. R Thurston. Martinus Nijhoff, Boston 1986; 143–8
   Google Scholar
• Venturini M. C., Quiroga M. A., Risso M. A., Di Lorenzo C., Omata Y., Venturini L., Godoy H. Mycotoxin T‐2 and aflatoxin B1 as immunosuppressants in mice chronically infected with Toxoplasma gondii. J Comp Pathol 1996; 115: 229–37
   PubMed Web of Science ®Google Scholar
• Jiang Y., Jolly P. E., Ellis W. O., Wang J. S., Phillips T. D., Williams J. H. Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians. Int Immunol 2005; 17: 807–14
   PubMed Web of Science ®Google Scholar
• Bosch F. X., Ribes J., Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 19: 271–85
   PubMed Web of Science ®Google Scholar
• Hall A. J., Wild C. P. Epidemiology of aflatoxin‐related disease. The toxicology of aflatoxins: human health, veterinary, and agricultural significance, D. L Eaton, J. D Groopman. Academic Press, San Diego 1994; 233–58
   Google Scholar
• Bosch F. X. Global epidemiology of hepatocellular carcinoma. Liver cancer, K Okuda, E Tabor. Churchill Livingston, New York 1997; 13–28
   Google Scholar
• Parkin D., Pisani P., Ferlay J. Estimates of the worldwide incidence of 18 major cancers in 1985. Int J Cancer 1993; 54: 594–606
   PubMed Web of Science ®Google Scholar
• Omer R. E., Bakker M. I., Veer P. V., Hoogenboom R. L. A. P., Polman T. H. G., Alink G. M., Idris M. O., Kadaru M. Y., Kok F. J. Aflatoxin and liver cancer in Sudan. Nutr Cancer 1998; 32: 174–80
   PubMed Web of Science ®Google Scholar
• Peers F. G., Gilman G. A., Linsell C. A. Dietary aflatoxins and human liver cancer. A study in Swaziland. Int J Cancer 1976; 17: 167–76
   PubMed Web of Science ®Google Scholar
• Peers F., Bosch X., Kaldor J., Linsell A., Pluumen M. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int J Cancer 1987; 39: 545–53
   PubMed Web of Science ®Google Scholar
• Wild C. P., Shrestha S. M., Anwar W. A., Montesano R. Field studies of aflatoxin exposure, metabolism and induction of genetic alterations in relation to HBV infection and hepatocellular carcinoma in The Gambia and Thailand. Toxicol Lett 1992; 64–65: 455–61
   PubMed Web of Science ®Google Scholar
• Harris C. C., Sun T. T. Multifactorial etiology of human liver cancer. Carcinogenesis 1984; 5: 697–701
   PubMed Web of Science ®Google Scholar
• Wogan G. N. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res 1992; 52((Suppl.))2114s–8s
   PubMedGoogle Scholar
• Yeh F. S., Shen K. N. Epidemiology and early diagnosis of primary liver cancer in China. Adv Cancer Res 1986; 47: 297–329
   PubMed Web of Science ®Google Scholar
• Groopman J. D., Wang J. S., Scholl P. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer. Can J Physiol Pharmacol 1996; 74: 203–9
   PubMed Web of Science ®Google Scholar
• IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Hepatitis viruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1994; 59: 45–221
   PubMedGoogle Scholar
• Wang L. Y., Hatch M., Chen C. J., Levin B., You S. L., Lu S. N., Wu M. H., Wu W. P., Wang L. W., Wang Q., Huang G. T., et al. Aflatoxin exposure and the risk of hepatocellular carcinoma in Taiwan. Int J Cancer 1996; 67: 620–5
   PubMed Web of Science ®Google Scholar
• Ross R. K., Yuan J. M., Yu M. C., Wogan G. N., Qian G. S., Tu J. T., Groopman J. D., Gao Y. T., Henderson B. E. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339: 943–6
   PubMed Web of Science ®Google Scholar
• Cova I., Wild C. P., Mehrotra R., Turusov V., Shirai T., Lambert V., Jacqet C., Tomatis I., Trepo C., Montesano R. Contribution of aflatoxin B1 and heptatis B virus infection in the induction of liver tumors in ducts. Cancer Res 1990; 50: 2156–63
   PubMed Web of Science ®Google Scholar
• Jolly P. E. Replicative characteristics of primary isolates of the human immunodeficiency virus type 1 in peripheral blood mononuclear cells, primary macrophages and CD4+ transformed T‐cell lines. Cell Molec Biol 1997; 43: 1057–65
   PubMed Web of Science ®Google Scholar
• Wang J. S., Qian G. S., Zarba A., He X., Zhu Y. R., Zhang B. C., Jacobson L., Gange S. J., Munoz A., Kensler T. W., Groopman J. D. Temporal patterns of aflatoxin‐albumin adducts in hepatitis B surface antigen‐positive and antigen‐negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1996; 5: 253–61
   PubMed Web of Science ®Google Scholar
• Bain V. Liver function tests. Liver Lett 1995; 2((1))
   Google Scholar
• Turner P. C., Mendy M., Whittle H. C., Fortuin M., Hall A. J., Wild C. P. Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Trop Med Int Health 2000; 5: 837–41
   PubMed Web of Science ®Google Scholar
• Marin D. E., Taranu I., Bunaciu R. P., Pascale F., Tudor D. S., Avram N., Sarca M., Cureu I., Criste R. D., Suta V., Oswald I. P. Changes in performance, blood parameters, humoral and cellular immune responses in weanling piglets exposed to low doses of aflatoxin. J Anim Sci 2002; 80: 1250–7
   PubMed Web of Science ®Google Scholar
• World Health Organization Department of Communicable Diseases Surveillance and Response. WHO/CDS/CSR/LY 2002.2: Hepatitis (http://www.who.int/emc)
   Google Scholar
• Sarkodie F., Adarkwa M., Adu‐Sarkodie Y., Candotti D., Acheampong J. W., Allain J. P. Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sanguinis 2001; 80: 142–7
   PubMed Web of Science ®Google Scholar
• Martinson F. E. A., Weigle K. A., Mushahwar I. K., Weber D. J., Royce R., Lemon S. M. Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. J Med Virol 1996; 48: 278–83
   PubMed Web of Science ®Google Scholar
• Chiaramonte M. T., Stroffolini T., Vian A., Stazi M. A., Floreani A., Lorenzoni U., Lobello S., Farinati F., Naccarato R. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999; 85: 2132–7
   PubMed Web of Science ®Google Scholar
• Wild C. P., Yin F., Turner P. C., Chemin I., Chapot B., Mendy M., Whittle H., Kirk G. D., Hall A. J. Environmental and genetic determinants of aflatoxin‐albumin adducts in the Gambia. Int J Cancer 2000; 86: 1–7
   PubMed Web of Science ®Google Scholar
• Chen S. Y., Chen C. J., Tsai W. Y., Ahsan H., Liu T. Y., Lin J. T., Santella R. M. Associations of plasma aflatoxin B1‐albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S‐transferase M1 and T1. Nutr Cancer 2000; 38: 179–85
   PubMed Web of Science ®Google Scholar
• Allen S. J., Wild C. P., Wheeler J. G., Riley E. M., Montesano R., Bennett S., Whittle H. C., Hall A. J., Greenwood B. M. Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Trans R Soc Trop Med Hygiene 1992; 58: 426–30
   Google Scholar
• Wild C. P., Fortuin M., Donato F., Whittle H. C., Hall A. J., Woll C. R., Montesano R. Aflatoxin, liver enzymes and hepatitis B virus infection in Gambian children. Cancer Epidemiol Biomarkers Prev 1993; 2: 555–61
   PubMed Web of Science ®Google Scholar
• Chen S. Y., Chen C. J., Chou S. R., Hsieh L. L., Wang L. Y., Tsai W. Y., Ahsan H., Santella R. M. Association of aflatoxin B1‐albumin adduct levels with hepatitis B surface antigen status among adolescents in Taiwan. Cancer Epidemiol Biomarkers Prev 2001; 10: 1223–6
   PubMed Web of Science ®Google Scholar
• Zhou T., Evans A. A., London W. T., Xia X., Zou H., Shen F., Clapper M. L. Glutathione S‐transferase expression in hepatitis B virus‐associated human hepatocellular carcinogenesis. Cancer Res 1997; 57: 2749–53
   PubMed Web of Science ®Google Scholar
• Kiyosawa K. T., Doseyama T., Tanaka E., Gibo Y., Yoshizawa K., Nakano Y., Furuta S., Akahane Y., Nishioka K., Purcell R. H., et al. Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671–5
   PubMed Web of Science ®Google Scholar
• Tong M. J., El‐Farra N. S., Reikes A. R., Co R. L. Clinical outcomes after transfusion‐associated hepatitis C. N Engl J Med 1995; 332: 1463–6
   PubMed Web of Science ®Google Scholar
• Montalto G., Cervello M., Giannitrapani L., Dantona F., Terranova A., Catagnetta L. A. M. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann NY Acad Sci 2002; 963: 13–20
   PubMed Web of Science ®Google Scholar
• Tradati F., Colombo M., Mannucci P. M., Rumi M. G., De Fazio C., Gamba G., Ciavarella N., Rocino A., Morfini M., Scaraggi A., Taioli E., the Study Group of the Association of Italian Hemophilia Centers. A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. Blood 1998; 91: 1173–7
   PubMed Web of Science ®Google Scholar
• Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamua T., Nakanishi K., Fujimoto I., Inoue A., Yamazaki H., Kawashima T. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797–801
   PubMed Web of Science ®Google Scholar
• Takano S., Yodosuka O., Imazeki F., Tagawa M., Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995; 21: 650–5
   PubMed Web of Science ®Google Scholar
• Fattovich G., Giustina G., Degos F., Diodati F., Tremolada F., Nevens F., Almasio P., Solinas A., Brouwer J. T., Thomas H., Realdi G., , the European Concerted Action on Viral Hepatitis, et al. Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. J Hepatol 1997; 27: 201–5
   PubMed Web of Science ®Google Scholar
• Bruno S., Silini E., Crosignani A., Borzio F., Leandro G., Bono F., Ast M., Rossi S., Larghi A., Cerino A., Rodda M., Mondelli M. U. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 1997; 24: 754–8
   Google Scholar